Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013943
Filing Date
2023-08-08
Accepted
2023-08-08 16:15:38
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enfn-20230630x10q.htm   iXBRL 10-Q 1828743
2 EX-31.1 enfn-20230630xex31d1.htm EX-31.1 12458
3 EX-31.2 enfn-20230630xex31d2.htm EX-31.2 11706
4 EX-32.1 enfn-20230630xex32d1.htm EX-32.1 5037
5 EX-32.2 enfn-20230630xex32d2.htm EX-32.2 5046
  Complete submission text file 0001558370-23-013943.txt   6181738

Data Files

Seq Description Document Type Size
6 EX-101.SCH enfn-20230630.xsd EX-101.SCH 32687
7 EX-101.CAL enfn-20230630_cal.xml EX-101.CAL 42619
8 EX-101.DEF enfn-20230630_def.xml EX-101.DEF 177690
9 EX-101.LAB enfn-20230630_lab.xml EX-101.LAB 323260
10 EX-101.PRE enfn-20230630_pre.xml EX-101.PRE 259219
53 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20230630x10q_htm.xml XML 937283
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40949 | Film No.: 231151531
SIC: 7372 Services-Prepackaged Software